สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์

Printed on 12 January 2026 04:19

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To

THE KLINIQUE MEDICAL CLINIC PUBLIC COMPANY LIMITED : KLINIQ

The Financial Statements which need to be revised ( 0 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
Data not found
Finanacial Statements ( 40 record(s) found)
NameYearStatusTypePeriodAs OfDetails
JAKPAISAN ESTATE PUBLIC COMPANY LIMITED2025ReviewedCompanyQ330/09/2025
JAKPAISAN ESTATE PUBLIC COMPANY LIMITED2025ReviewedCompanyQ230/06/2025
JAKPAISAN ESTATE PUBLIC COMPANY LIMITED2025ReviewedCompanyQ131/03/2025
JAKPAISAN ESTATE PUBLIC COMPANY LIMITED2024AuditedEquity Method StatementYear31/12/2024
JAKPAISAN ESTATE PUBLIC COMPANY LIMITED2024 CompanyYear31/03/2024
JAKPAISAN ESTATE PUBLIC COMPANY LIMITED2024AuditedCompanyYear31/12/2024
JAKPAISAN ESTATE PUBLIC COMPANY LIMITED2024ReviewedEquity Method StatementQ330/09/2024
JAKPAISAN ESTATE PUBLIC COMPANY LIMITED2024ReviewedCompanyQ330/09/2024
JAKPAISAN ESTATE PUBLIC COMPANY LIMITED2024ReviewedEquity Method StatementQ230/06/2024
JAKPAISAN ESTATE PUBLIC COMPANY LIMITED2024ReviewedCompanyQ230/06/2024
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 12 record(s) found)
DateTimeHeadingLink
13/11/202519:47Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025
13/08/202519:03Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
27/02/202519:51Management Discussion and Analysis Yearly Ending 31 Dec 2024
15/11/202412:47Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024 (Revised)
14/11/202419:15Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024
14/08/202418:57Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
14/05/202417:13Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
28/02/202417:53Management Discussion and Analysis Yearly Ending 31 Dec 2023
14/11/202318:55Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023
15/08/202318:54Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found

Last updated on 11 January 2026